000 02350 a2200601 4500
005 20250515153321.0
264 0 _c20090605
008 200906s 0 0 eng d
022 _a0363-6119
024 7 _a10.1152/ajpregu.90822.2008
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aMortensen, Stefan P
245 0 0 _aATP-induced vasodilation and purinergic receptors in the human leg: roles of nitric oxide, prostaglandins, and adenosine.
_h[electronic resource]
260 _bAmerican journal of physiology. Regulatory, integrative and comparative physiology
_cApr 2009
300 _aR1140-8 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAdenosine
_xmetabolism
650 0 4 _aAdenosine Triphosphate
_xadministration & dosage
650 0 4 _aAdult
650 0 4 _aBlood Flow Velocity
650 0 4 _aCyclooxygenase Inhibitors
_xpharmacology
650 0 4 _aEndothelium, Vascular
_xmetabolism
650 0 4 _aEnzyme Inhibitors
_xpharmacology
650 0 4 _aHumans
650 0 4 _aIndomethacin
_xpharmacology
650 0 4 _aInfusions, Intra-Arterial
650 0 4 _aLower Extremity
650 0 4 _aMale
650 0 4 _aMuscle, Skeletal
_xblood supply
650 0 4 _aMuscle, Smooth, Vascular
_xmetabolism
650 0 4 _aNitric Oxide
_xmetabolism
650 0 4 _aNitric Oxide Synthase
_xantagonists & inhibitors
650 0 4 _aProstaglandins
_xmetabolism
650 0 4 _aPurinergic P1 Receptor Antagonists
650 0 4 _aRNA, Messenger
_xmetabolism
650 0 4 _aReceptors, Purinergic P1
_xmetabolism
650 0 4 _aReceptors, Purinergic P2
_xgenetics
650 0 4 _aReceptors, Purinergic P2X
650 0 4 _aReceptors, Purinergic P2Y2
650 0 4 _aRegional Blood Flow
650 0 4 _aSignal Transduction
_xdrug effects
650 0 4 _aTheophylline
_xpharmacology
650 0 4 _aVasodilation
_xdrug effects
650 0 4 _aYoung Adult
650 0 4 _aomega-N-Methylarginine
_xpharmacology
700 1 _aGonzález-Alonso, José
700 1 _aBune, Laurids T
700 1 _aSaltin, Bengt
700 1 _aPilegaard, Henriette
700 1 _aHellsten, Ylva
773 0 _tAmerican journal of physiology. Regulatory, integrative and comparative physiology
_gvol. 296
_gno. 4
_gp. R1140-8
856 4 0 _uhttps://doi.org/10.1152/ajpregu.90822.2008
_zAvailable from publisher's website
999 _c18567896
_d18567896